Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Sinclair & Co.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Bioptigen Unveils Image Analysis Software - New software delivers automated retinal layer segmentation of mouse SDOCT images - Bioptigen.com
Bioptigen Unveils Image Analysis Software

 

PRZOOM - /newswire/ - Research Triangle Park, NC, United States, 2011/04/29 - New software delivers automated retinal layer segmentation of mouse SDOCT images - Bioptigen.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bioptigen, Inc., a medical device company whose innovative ophthalmic imaging technologies produce highly resolved images for researchers and clinicians, has released a new software package, InVivoVue™ Miner.

InVivoVue Miner automates analysis of retinal layers of mouse models acquired in vivo with Bioptigen’s spectral domain optical coherence tomography imaging systems. InVivoVue Miner automatically segments eight discrete layers of the rodent retina; aggregates thickness results into a common ETDRS-like grid; and generates graphical reports, thickness maps and intensity projections of all available layers.

Armed with InVivoVue Miner software, scientists can visualize and quantify findings related to retinal disease progression and therapeutic modalities with a minimum of user intervention.

Dr. Eric Buckland, president and CEO, said that the batch processing functionality of Bioptigen’s new software enables high throughput analysis of large data sets for both prospective and retrospective studies.

“Researchers working within the pre-clinical arena want this software because it advances their ability to quantify, validate and publish results more rapidly and less laboriously than is currently possible with other methods of managing OCT image data,” Buckland said. “By equipping researchers in their quest to better understand early disease progression, Bioptigen continues to open new avenues for biological exploration, monitoring of disease progression, and development of therapeutic interventions.”

Bioptigen will unveil its InVivoVue Miner software at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting taking place May 1-5 in Fort Lauderdale, Fla.

Bioptigen originally created its proprietary non-invasive spectral domain ophthalmic imaging platform – called Envisu™ – specifically for small animal imaging. The Envisu family of imaging systems uses low-power, near-infrared light to acquire, process, display and store real-time, depth-resolved images of ocular tissues. Envisu delivers resolution 100 times finer than standard ultrasound, and is suitable for analyzing tissue microstructure with features as small as two micrometers.

Bioptigen (bioptigen.com) delivers highly sophisticated medical imaging devices renowned for their performance and versatility. The company’s passion for collaboration and innovation enables life-changing advances in health care through the boundless potential of its revolutionary imaging technologies.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Sinclair & Co.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Bioptigen Unveils Image Analysis Software

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Karen Stinneford - Sinclair-Co.com 
919-833-9102 kstinneford[.]sinclair-co.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sinclair & Co. securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Sinclair & Co. / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Global Hemoglobinopathy Market Worth US$ 788M by 2024 According to Persistence Market Research
Dentsu Announces its Corporate Venture Capital Fund Dentsu Ventures Investment in Grail
Xenex Receives Top Honors from Frost & Sullivan for LightStrike™ - the Only Pulsed Xenon UV Disinfection System in the Healthcare Market
Partners HealthCare and GE Healthcare Launch 10-year Collaboration to Integrate Artificial Intelligence into Every Aspect of the Patient Journey
US Acute Care Solutions Celebrates 2-Year Anniversary
GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with Coronary CT Angiography
Telehealth Vendors Expand mHealth Portfolio to Conquer New Growth Opportunities Finds Frost & Sullivan
GE Healthcare Acquires Asymptote for Complete, Digitally-enabled Cryogenic Cold Chain Technology Supporting Safe Manufacture And Delivery Of Cellular
ANVISA Approval for EMCM Facilitates the Progress of Leader Biomedical Operations in Brazil
GE Healthcare Expands Digital Maternal-Infant Care Offerings with Acquisition of Monica Healthcare

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  Persistence Market Research (P) Ltd

Visit  NAKIVO, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today